Nexavar articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/16 09:08
2013/05/16 09:08
4d
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar® (sorafenib) tablets, Stivarga® (regorafenib) tablets and the recently U.S. Food and Drug Administration...
2013/05/16 09:08
2013/05/16 09:08
Latest videos
2013/05/16 09:08
2013/05/16 09:08
Latest from Twitter
2013/05/15 13:22
2013/05/15 13:22
5d
The PFS/OS data from the Nexavar arm of the pivotal Aveo study (the green triangle) is another outlier on the graph. With a 9.1 month median PFS, the expectation would be for a median OS of around...
2013/05/15 12:08
2013/05/15 12:08
5d
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate...
2013/05/15 04:28
2013/05/15 04:28
6d
Indian and U.S. national flags flutter in front of the Presidential Palace, ahead of the visit of U.S. President George W. Bush in New Delhi February 28, 2006. A U.S. think tank on Tuesday...
2013/05/06 17:22
2013/05/06 17:22
14d
If you haven't done so already, I recommend downloading and reading this week's issue of the Cancer Letter. Editor and Publisher Paul Goldberg has a definitive account of last week's panel meeting...
FDA Nexavar
MENTIONED
2013/05/02 21:09
2013/05/02 21:09
18d
Aveo Pharmaceuticals Inc. failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as...
2013/05/02 07:45
2013/05/02 07:45
18d
WASHINGTON -- The Obama administration placed India on a special trade blacklist Wednesday, a move some public health advocates said was retaliation for the country allowing generic versions of...
2013/05/01 04:22
2013/05/01 04:22
20d
CAMBRIDGE, Mass. (TheStreet) -- Next week is crucial for Aveo Oncology.(AVEO) On Tuesday, the FDA will post to its web site the agency's clinical review of Aveo's experimental kidney cancer drug...
2013/04/25 10:22
2013/04/25 10:22
25d
I understand tivozanib met the study's primary endpoint by demonstrating a statistically significant progression-free survival (PFS) benefit. And I also know FDA has approved other kidney cancer drugs...
2013/04/25 10:22
2013/04/25 10:22
25d
Aveo believes overall survival of tivozanib was snake bit by a study design that allowed kidney cancer patients treated initially with Nexavar to receive effective, subsequent therapy, including...
Nexavar
MENTIONED
2013/04/25 10:22
2013/04/25 10:22
25d
CAMBRIDGE, Mass. (TheStreet) -- Next week is crucial for Aveo Oncology.(AVEO) On Tuesday, the FDA will post to its web site the agency's clinical review of Aveo's experimental kidney cancer drug...